These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17419608)

  • 1. Nuclear phospholipase C gamma: punctate distribution and association with the promyelocytic leukemia protein.
    Ferguson BJ; Dovey CL; Lilley K; Wyllie AH; Rich T
    J Proteome Res; 2007 May; 6(5):2027-32. PubMed ID: 17419608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
    Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
    Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress responses of PML nuclear domains are ablated by ataxin-1 and other nucleoprotein inclusions.
    Dovey CL; Varadaraj A; Wyllie AH; Rich T
    J Pathol; 2004 Aug; 203(4):877-83. PubMed ID: 15258989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies.
    Fleischer S; Wiemann S; Will H; Hofmann TG
    Exp Cell Res; 2006 Apr; 312(6):901-12. PubMed ID: 16412420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.
    Cohen N; Sharma M; Kentsis A; Perez JM; Strudwick S; Borden KL
    EMBO J; 2001 Aug; 20(16):4547-59. PubMed ID: 11500381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CK2 and PML: regulating the regulator.
    Lallemand-Breitenbach V; de Thé H
    Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.
    Tavalai N; Papior P; Rechter S; Leis M; Stamminger T
    J Virol; 2006 Aug; 80(16):8006-18. PubMed ID: 16873257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus.
    Nakahara T; Lambert PF
    Virology; 2007 Sep; 366(2):316-29. PubMed ID: 17543368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.
    Kentsis A; Dwyer EC; Perez JM; Sharma M; Chen A; Pan ZQ; Borden KL
    J Mol Biol; 2001 Sep; 312(4):609-23. PubMed ID: 11575918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.
    Carlile GW; Tatton WG; Borden KL
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):691-6. PubMed ID: 9794812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
    Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein.
    Daniels MJ; Marson A; Venkitaraman AR
    Nat Struct Mol Biol; 2004 Nov; 11(11):1114-21. PubMed ID: 15467728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic nuclear localization of the baculovirus proteins IE2 and PE38 during the infection cycle: the promyelocytic leukemia protein colocalizes with IE2.
    Murges D; Quadt I; Schröer J; Knebel-Mörsdorf D
    Exp Cell Res; 2001 Apr; 264(2):219-32. PubMed ID: 11262179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of NFAT by promyelocytic leukemia protein.
    Lo YH; Wu CC; Shih HM; Lai MZ
    Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.